Patents by Inventor Long Ping Victor Tse

Long Ping Victor Tse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for antibody-evading virus vectors
    Patent number: 11840555
    Abstract: The present invention provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The invention also provides methods of administering the virus vectors and virus capsids of the invention to a cell or to a subject in vivo.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: December 12, 2023
    Assignees: The University of North Carolina at Chapel Hill, University of Florida Research Foundation, Inc.
    Inventors: Aravind Asokan, Mavis Agbandje-McKenna, Long Ping Victor Tse, Brittney Gurda
  • METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS
    Publication number: 20220089651
    Abstract: The present invention provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The invention also provides methods of administering the virus vectors and virus capsids of the invention to a cell or to a subject in vivo.
    Type: Application
    Filed: November 15, 2021
    Publication date: March 24, 2022
    Inventors: Aravind Asokan, Mavis Agbandje-McKenna, Long Ping Victor Tse, Brittney Gurda
  • Methods and compositions for antibody-evading virus vectors
    Patent number: 11208438
    Abstract: The present invention provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The invention also provides methods of administering the virus vectors and virus capsids of the invention to a cell or to a subject in vivo.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: December 28, 2021
    Assignees: The University of North Carolina at Chapel Hill, University of Florida Research Foundation, Inc.
    Inventors: Aravind Asokan, Mavis Agbandje-McKenna, Long Ping Victor Tse, Brittney Gurda
  • METHODS AND COMPOSITIONS FOR ENGINEERED ASSEMBLY ACTIVATING PROTEINS (EAAPS)
    Publication number: 20210147487
    Abstract: The present invention relates to compositions and methods comprising an engineered assembly activating protein (EAAP).
    Type: Application
    Filed: April 4, 2019
    Publication date: May 20, 2021
    Inventors: Aravind Asokan, Sven Moller-Tank, Long Ping Victor Tse
  • METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS
    Publication number: 20200399321
    Abstract: The present invention provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The invention also provides methods of administering the virus vectors and virus capsids of the invention to a cell or to a subject in vivo.
    Type: Application
    Filed: July 6, 2020
    Publication date: December 24, 2020
    Inventors: Aravind Asokan, Mavis Agbandje-McKenna, Long Ping Victor Tse, Brittney Gurda
  • Methods and compositions for antibody-evading virus vectors
    Patent number: 10745447
    Abstract: The present invention provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The invention also provides methods of administering the virus vectors and virus capsids of the invention to a cell or to a subject in vivo.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: August 18, 2020
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Aravind Asokan, Mavis Agbandje-McKenna, Long Ping Victor Tse, Brittney Gurda
  • METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS
    Publication number: 20190048041
    Abstract: The present invention provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The invention also provides methods of administering the virus vectors and virus capsids of the invention to a cell or to a subject in vivo.
    Type: Application
    Filed: September 28, 2016
    Publication date: February 14, 2019
    Inventors: Aravind Asokan, Mavis Agbandje-McKenna, Long Ping Victor Tse, Brittney Gurda